Mohammed F. EL-Yamany

Crosstalk between PI3K/AKT/KLF4 signaling and microglia M1/M2 polarization as a novel mechanistic approach towards flibanserin repositioning in parkinson's disease

Nancy K. El-Deeb, Dalia M. El-Tanbouly, Mohamed Khattab et al. · International Immunopharmacology · 2022 · 37 citations

Life Sciences, Neurobiology, Neuroscience +14

Modulation of AMPK by esomeprazole and canagliflozin mitigates methotrexate-induced hepatotoxicity: involvement of MAPK/JNK/ERK, JAK1/STAT3, and PI3K/Akt signaling pathways

Ahmed M. El‐Dessouki, Mohamed E. Kaml, Mohammed F. EL-Yamany · Naunyn-Schmiedeberg s Archives of Pharmacology · 2025 · 16 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Crosstalk between SIRT1/Nrf2 signaling and NLRP3 inflammasome/pyroptosis as a mechanistic approach for the neuroprotective effect of linagliptin in Parkinson’s disease

Wessam Z. Ghaith, Walaa Wadie, Mohammed F. EL-Yamany · International Immunopharmacology · 2024 · 14 citations

Life Sciences, Neuroscience, Pharmacology +17

Novel trajectories of the NK1R antagonist aprepitant in rotenone-induced Parkinsonism-like symptoms in rats: Involvement of ERK5/KLF4/p62/Nrf2 signaling axis

Asmaa M. El-Deeb, Ahmed F. Mohamed, Mohammed F. EL-Yamany et al. · Chemico-Biological Interactions · 2023 · 12 citations

Life Sciences, Neuroscience, Pharmacology +16